HIGHLIGHTS
- who: Lung Adenocarcinoma and colleagues from the Department of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China have published the research work: A Novel Immune-Related Gene Signature Predicts Prognosis of Lung Adenocarcinoma, in the Journal: BioMed Research International 9 of 29/07/2021
- what: This study was aimed at finding an immune-related gene signature for predicting LUAD patient outcomes. The authors first developed an epigenetic-related prognostic signature based on a TCGA dataset and then validated it in two GEO datasets. In the research , BTK and CCR6 were showing favorably influence . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.